化学菌调节剂:药物开发策略和新型监管机制
Yu Dong1, Xu-Xu Zhuang1, Yi-Ting Wang1
1State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, 999078, Macau.
Pharmacological research
|June 22, 2023
概括
线粒体的选择性降解 (线粒体衰变) 是健康的关键. 本综述总结了线粒的机制,提出了表征系统,分析了方法,并确定了开发有效线粒药物的目标.
科学领域:
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 线粒体平衡对于预防神经退行,心血管疾病,代谢障碍和癌症等疾病至关重要.
- 线粒体,即线粒体通过自的选择性降解,是重要的质量控制机制.
- 小分子菌调节器是研究和药物开发的宝贵工具.
研究的目的:
- 为了审查基因的基础上的分子机制.
- 引入一个标准化的线粒调节器特性系统 (MMCS).
- 在过去的二十年里,批判性地分析了表征线粒调节器的方法,并确定了新的治疗点.
主要方法:
- 在过去20年中发表的线粒研究的综合文献综述.
- 分析用于表征线粒调节器的方法.
- 鉴定和建议药理学菌体干预的新目标.
主要成果:
- 在当前的线粒细胞调节器研究中发现了频繁的方法缺陷,导致了不可靠的结论.
- 提出了线粒细胞调节器表征系统 (MMCS),以提高研究的严谨性.
- 在各种疾病模型中突出了线粒细胞调节器的有前途的治疗应用.
结论:
- 强调在线粒研究中需要高标准的方法.
- 旨在促进治疗用途的安全有效的线粒调节剂的开发.
- 提供了药理学菌体调节未来研究的路线图.
相关概念视频
Electron Transport Chain: Complex I and II
14.6K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.6K
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Regulation of Metabolism
9.5K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
9.5K
Targets for Drug Action: Overview
6.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.5K
Phase II Reactions: Methylation Reactions
240
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
240
Drug Discovery: Overview
8.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.1K


